Cancer Capital (CNCL) 10-Q 12 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 12, 2019
Document And Entity Information
Entity Registrant Name	CANCER CAPITAL CORP
Entity Central Index Key	0001130889
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Entity Incorporation, State or Country Code	WY
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity File Number	000-32363
Is Entity's Reporting Status Current?	Yes
Entity Interactive Data Current	Yes
Is Entity Emerging Growth Company?	true
Elected Not To Use the Extended Transition Period	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Common Stock, Shares Outstanding		6,150,000
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current Assets
Cash	$ 233	$ 168
Total current assets	233	168
Total assets	233	168
Current Liabilities
Accounts payable - related party	11,100	6,600
Accounts payable		1,100
Notes payable - related party	120,325	112,825
Notes payable	82,575	82,575
Accrued interest - related party	41,883	34,948
Accrued interest	39,164	34,211
Total current liabilities	295,047	272,259
Total liabilities	295,047	272,259
STOCKHOLDERS' DEFICIT
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding	6,150	6,150
Additional paid in capital	47,050	47,050
Accumulated deficit	(348,014)	(325,291)
Stotal stockholders' deficit	(294,814)	(272,091)
Total liabilities and stockholders' deficit	$ 233	$ 168

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	20,000,000	20,000,000
Common stock, issued	6,150,000	6,150,000
Common stock, outstanding	6,150,000	6,150,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
REVENUES
EXPENSES
General and administrative	2,710	2,615	10,835	10,932
Total expenses	2,710	2,615	10,835	10,932
Loss from operations before other expense	(2,710)	(2,615)	(10,835)	(10,932)
Other income (expense) non-operating
Interest expense - related party	(2,379)	(2,100)	(6,935)	(6,195)
Interest expense	(1,651)	(1,651)	(4,953)	(4,953)
Total other expense	(4,030)	(3,751)	(11,888)	(11,148)
Loss from operations before taxes	(6,740)	(6,366)	(22,723)	(22,080)
Taxes
Net loss	$ (6,740)	$ (6,366)	$ (22,723)	$ (22,080)
Net loss per share - Basic and diluted	$ 0	$ 0	$ 0	$ 0
Weighted average shares outstanding	6,150,000	6,150,000	6,150,000	6,150,000

Condensed Statement of Stockhol

Condensed Statement of Stockholders’ Deficit (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	6,150,000
Beginning balance, amount at Dec. 31, 2017	$ 6,150	$ 47,050	$ (296,821)	$ (243,621)
Net loss			(9,373)	(9,373)
Ending balance, shares at Mar. 31, 2018	6,150,000
Ending balance, amount at Mar. 31, 2018	$ 6,150	47,050	(306,194)	(252,994)
Beginning balance, shares at Dec. 31, 2017	6,150,000
Beginning balance, amount at Dec. 31, 2017	$ 6,150	47,050	(296,821)	(243,621)
Net loss				(22,080)
Ending balance, shares at Sep. 30, 2018	6,150,000
Ending balance, amount at Sep. 30, 2018	$ 6,150	47,050	(318,901)	(265,701)
Beginning balance, shares at Mar. 31, 2018	6,150,000
Beginning balance, amount at Mar. 31, 2018	$ 6,150	47,050	(306,194)	(252,994)
Net loss			(6,341)	(6,341)
Ending balance, shares at Jun. 30, 2018	6,150,000
Ending balance, amount at Jun. 30, 2018	$ 6,150	47,050	(312,535)	(259,335)
Net loss			(6,366)	(6,366)
Ending balance, shares at Sep. 30, 2018	6,150,000
Ending balance, amount at Sep. 30, 2018	$ 6,150	47,050	(318,901)	(265,701)
Beginning balance, shares at Dec. 31, 2018	6,150,000
Beginning balance, amount at Dec. 31, 2018	$ 6,150	47,050	(325,291)	(272,091)
Net loss			(9,309)	(9,309)
Ending balance, shares at Mar. 31, 2019	6,150,000
Ending balance, amount at Mar. 31, 2019	$ 6,150	47,050	(334,600)	(281,400)
Beginning balance, shares at Dec. 31, 2018	6,150,000
Beginning balance, amount at Dec. 31, 2018	$ 6,150	47,050	(325,291)	(272,091)
Net loss				(22,723)
Ending balance, shares at Sep. 30, 2019	6,150,000
Ending balance, amount at Sep. 30, 2019	$ 6,150	47,050	(348,014)	(294,814)
Beginning balance, shares at Mar. 31, 2019	6,150,000
Beginning balance, amount at Mar. 31, 2019	$ 6,150	47,050	(334,600)	(281,400)
Net loss			(6,674)	(6,674)
Ending balance, shares at Jun. 30, 2019	6,150,000
Ending balance, amount at Jun. 30, 2019	$ 6,150	47,050	(341,274)	(288,074)
Net loss			(6,740)	(6,740)
Ending balance, shares at Sep. 30, 2019	6,150,000
Ending balance, amount at Sep. 30, 2019	$ 6,150	$ 47,050	$ (348,014)	$ (294,814)

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash Flows from Operating Activities
Net Loss	$ (22,723)	$ (22,080)
Adjustments to reconcile net loss to cash provided (used) by operating activities:
Expenses paid by related party	4,500	5,100
Changes in assets and liabilities:
Increase (decrease) accounts payable	(1,100)	1,100
Increase in accrued interest - related party	6,935	6,195
Increase in accrued interest	4,953	4,953
Net cash provided (used) by operating activities	(7,435)	(4,732)
Cash Flows from Investing Activities
Net cash provided by investing activities
Cash Flows from Financing Activities
Proceeds from notes payable - related party	7,500	4,500
Net cash provided by financing activities	7,500	4,500
Increase (decrease) in cash	65	(232)
Cash and cash equivalents at beginning of period	168	315
Cash and cash equivalents at end of period	233	83
Supplemental Cash Flow Information:
Cash paid for interest
Cash paid for income taxes

Basis of Financial Statement Pr

Basis of Financial Statement Presentation	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Financial Statement Presentation	NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2018 Annual Report on Form 10-K. Operating results for the nine months ended September 30, 2019 are not necessarily indicative of the results to be expected for year ending December 31, 2019.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 3 – RELATED PARTY TRANSACTIONS During the nine months ended September 30, 2019, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $4,500, resulting in the Company owing the shareholder $11,100 and $6,600 at September 30, 2019 and December 31, 2018, respectively. During the nine months ended September 30, 2019, a shareholder loaned the Company $7,500. The notes bear interest at 8% and are due on demand. Notes payable – related party at September 30, 2019 and December 31, 2018 were $120,325 and $112,825, respectively. Accrued interest at September 30, 2019 and December 31, 2018 was $41,883 and $34,948, respectively.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
Subsequent Events	NOTE 4 – SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Related Party Transactions [Abstract]
Consulting, administrative and professional costs provided for or paid on behalf of Company by shareholder	$ 4,500
Amounts due to shareholder	11,100	$ 6,600
Amounts loaned to Company by shareholder	7,500
Notes payable - related party	120,325	112,825
Accrued interest on notes payable - related party	$ 41,883	$ 34,948
Interest rate on notes payable - related party	8.00%